FCGR3A and Thrombocytopenia: FcγRIIa triggers platelet activation and aggregation, and FcγRIIIa stimulates antibody-dependent cellular cytotoxicity, which may contribute to thrombocytopenia and symptoms of an infusion-related reaction, respectively [32,33].